Trial Profile
Study of the Effect of Vildagliptin on Glucagon Counterregulation Response During Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 25 Sep 2013 Status changed from recruiting to completed.
- 25 Sep 2013 Primary endpoint 'Glucagon-levels' has been met.
- 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.